We evaluated a commercial (Radioassay Systems) radioimmunoassay kit for testosterone in which a double-antibody method and an 1251 tracer are used. The 50-FL serum sample is assayed directly with no pre-extraction step. The assay system has good sensitivity (0.01 1.zg/L), good precision (CV 5.2%), and little cross reactivity between testosterone and other androgens. Results compared well with those by a tritiated radioimmunoassay involving extraction (r = 0.98). Values obtained for 97 children compared well with published pediatric normal values. Evidently, this kit provides a rapid and reliable measurement of testosterone in serum specimens and is acceptable for use with pediatric patients.
Highly sensitive and accurate radioimmunoassays (RIA) for testosterone have been available for many years. However, because of the multiple types of adrenal and gonadal androgens present in serum, most assay systems require a separation step by column chromatography before the RIA to obtain an accurate result. This separation step is time consuming, requires exposure to toxic agents, and necessitates the use of relatively large serum samples.
Testosterone is measured to evaluate adrenal-gonadal tumors, early or delayed puberty, metabolic abnormalities such as congenital adrenal hyperplasia, or ambiguous genitalia in the newborn. Large blood samples are not always available and the normally low concentration of testosterone in the prepubertal specimen makes antibody cross reactivity among androgens a greater problem.
We evaluated a commercial testosterone system that has low cross reactivity, does not require a separation step, uses small serum samples, and has the convenience of an 125j tracer system.
Materials and Methods

Instruments
We used a Model 5210 Auto-Gamma Counter (Packard Instruments, Downer's Grove, IL 60515) for the radioactive counting and a Model 1860 calculator (Monroe Calculators, Columbus, OH 43215) for the log-logit data reduction.
Multi-volume Eppendorf
pipettors (Scientific Products, Obetz, OH 43207) with 0.2% precision (2 4JmL) were used for pipetting specimens and reagent solutions.
Reagents
Testosterone kits. The 1251 testosterone kits (Radioassay Systems, Carson, CA 90746) include the following reagents: rabbit antitestosterone antibody generated from the antigen, testosterone-19-carboxymethylether-bovine serum albumin; lmIlabeled testosterone (specific activity, 2000-3000 CiJg) in phosphosaline-gelatin buffer (0.1 molJL, pH 7.0); second antibody (goat anti-rabbit gamma-globulin) in Serum or plasma specimens can be used with this kit. They can be stored either at 2-8 #{176}C for one week or frozen (maximum three months) until assayed. As part of the evaluation, we assayed 97 serum specimens obtained from hospitalized children with no evidence of an endocrinological or medical problem that would alter their circulating concentrations of testosterone. All specimens were stored at -20 #{176}C until assayed.
Other reagents. We used the following materials in assessing the specificity of the testosterone antiserum: 5a-dihydrotestosterone, 5/3-dthydrostestosterone, androsterone, androstenedione,and progesterone (allfrom Sigma Chemical Co., St. Louis, MO 63178). Solutions were made in absolute ethanol, aliquots were evaporated, and 50 pL of "free" serum (supplied with the kit) was added to the residue in each tube before the RIA.
Procedure
Set up the assay in glass 12 x 75 mm tubes. All reagents are used as received, with the following exceptions: (a) The 10 ,ugfL testosterone standard is deleted and 0.05 g/L testosterone standard is added (dilute the 0.10 jzg/L testosterone standard with an equal volume of the "free" serum supplied); and (b) specimens from prepubertal boys are assayed without the suggested dilution step for specimens from males.
The procedure is as follows. Apportion the standards, controls, and samples (50 pL, in duplicate) into their respective tubes. Add 100 /LL of testosterone-binding globulininhibitor (TBGI) solution and shake the tubes for lOs. Add '251-labeled testosterone tracer and first antibody, 0.5 mL each, to appropriate tubes. Vortex-mix the contents of the tubes and incubate them for 2 h at 37#{176}C. Add 100 L of second antibody to all tubes (except the total-count tubes) and incubate for 60 mm at 37 #{176}C. Centrifuge the tubes for 20 mm (4#{176}C, 1000 x g), decant, blot, and count the radioactivity in the precipitate for 2 mm.
Total time involved is about 4 h for this five-pipetting-step assay. Results are obtained by a calculator program in which a log-logit transformation and weighted least-squares regression analysis of data are used (1).
Results
Sensitivity and range. The manufacturer's reported sensitivity of this system is <0.05 .tg/L. We estimated the sensitivity (minimal detectable concentration at the 95% confidence level), according to an established method (2), to be 0.01 g/L. The range of the assay's standards is 0.05-5.00 pg of testosterone per liter.
Specificity.
The standard curves obtained with this system (Figure 1) show almost no variance (<1.5%) in comparing the testosterone curve with the curve for the combination of testosterone+ 5a-dihydrotestosterone(equalconcentrations of each steroid).
For cross-reactivity studies we evaluated Table 3 . Interassay variation was tested on low, medium, and high-concentration pooled sera (n = 8 for each). Coefficients of variation (CVs) ranged from 9.5% to 11.1%. Intra-assay CVs of the low (n = 10), medium (n = 5), and high (n = 10) pools were 12.5%, 12.5%, and 5.2%, respectively. only those steroid concentrations seen clinically; their curves are shown in Figure 2 . The manufacturer lists the actual percent cross reactivity for these and other steroids in its directional insert. Recove,y and parallelism. Tables 1 and 2 summarize the respective recovery study and parallelism study assessed with this kit. In the recovery study we added a known amount of testosterone to a low-concentration serum sample; in the parallelism study we used a high-concentration serum sample diluted accordingly with the "free" serum of the kit. In either study, each sample's results (n = 6) were averaged and the percentage observed of expected was
calculated.
The results demonstrate that the assay characteristics are linear over the assay range (0.05-5.00 pgfL). Precision. Inter-and intra-assay variations were deter- 
Accuracy.
We assessed the correlation between the 'WIlabeled testosterone no-extraction method and a standard tritiated method that involved extraction before the RIA. 
In comparing our results
with established reference ranges for children (5), our values appeared to correlate well (Tables 4 and 5 ).
Discussion
Our goal was to evaluate a commercial testosterone kit that would be adaptable to the limitations associated with pediatric use. As our data demonstrate, direct serum RIA for testosterone can be accomplished without the loss of sensitivity, specificity, precision, or accuracy. The sensitivity of 
